In a move which will make treatment of tuberculosis simpler, accessible and affordable, global non-profit drug developer, TB Alliance has tied up with domestic company, Macleods Pharmaceuticals to develop and commercialise 'breakthrough’ therapy, Pretomanid in a majority of high-burden countries, including India.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2MVlvlb
No comments:
Post a Comment